The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
reported to the Securities and Exchange Commission (SEC)
by insider Foletta Mark G since year 2005.
The trader's CIK number is 1236389.
At the time of this reporting, Foletta Mark G is the Senior VP, Finance & CFO of
Amylin Pharmaceuticals Inc
(stock ticker symbol AMLN).
Stock purchases, sales, and option exercises reported by Foletta Mark G since 2005.
Trade Date
Symbol
Company Name (Issuer)
Trade Type
Shares
Price ($)
Value ($)
2007-09-28
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
3,000
13.25
39,750
2007-09-28
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
49.98
149,931
2007-08-31
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
3,000
13.25
39,750
2007-08-31
AMLN
Amylin Pharmaceuticals Inc
Sale
3,000
48.86
146,574
2007-07-31
AMLN
Amylin Pharmaceuticals Inc
Sale
3,500
47.43
166,022
2007-07-31
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
3,500
13.25
46,375
2007-06-29
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
13.25
33,125
2007-06-29
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
41.38
103,455
2007-05-31
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
6,500
13.25
86,125
2007-05-31
AMLN
Amylin Pharmaceuticals Inc
Sale
6,500
45.79
297,662
2007-04-30
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
42.32
105,800
2007-04-30
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
13.25
33,125
2007-03-30
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
37.61
94,025
2007-03-30
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
13.25
33,125
2007-02-28
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
12.60
31,500
2007-02-28
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
38.82
97,050
2007-01-31
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
11.95
29,875
2007-01-31
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
39.00
97,500
2006-12-29
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
11.95
29,875
2006-12-29
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
35.89
89,725
2006-11-30
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
40.76
101,900
2006-11-30
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
11.54
28,843
2006-10-31
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
11.12
27,812
2006-10-31
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
43.91
109,774
2006-09-15
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
44.35
88,701
2006-09-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
10.50
21,000
2006-08-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
9.88
19,750
2006-08-15
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
41.76
83,520
2006-07-17
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
11.56
23,125
2006-07-17
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
48.38
96,764
2006-05-15
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
42.75
85,500
2006-05-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
11.11
22,225
2006-04-17
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
9.62
19,250
2006-04-17
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
48.84
97,680
2006-03-15
AMLN
Amylin Pharmaceuticals Inc
Sale
2,500
43.91
109,774
2006-03-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,500
8.33
20,816
2006-02-15
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
1,500
5.73
8,595
2006-02-15
AMLN
Amylin Pharmaceuticals Inc
Sale
1,500
37.70
56,550
2006-01-17
AMLN
Amylin Pharmaceuticals Inc
Option Exercise
2,000
5.73
11,460
2006-01-17
AMLN
Amylin Pharmaceuticals Inc
Sale
2,000
43.00
86,000
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Foletta Mark G
(Senior VP, Finance & CFO of Amylin Pharmaceuticals Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.
